Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas

Regulatory Peptides

Volumn 161, Issue 1-3, 2010, Pages 1-7

  Muñoz, Marina C ^a   Giani, Jorge F ^a   Dominici, Fernando P ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Akt; Angiotensin II; Angiotensin (1 7); GSK 3 ; Mas receptor

Indexed keywords

ANGIOTENSIN[1-7]; GLYCOGEN SYNTHASE KINASE 3BETA; HORMONE RECEPTOR; INSULIN; MAS RECEPTOR; PROTEIN KINASE B; SERINE; THREONINE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HORMONE ACTION; IN VIVO STUDY; INSULIN RESISTANCE; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

RATTUS;

EID: 77950341044     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.02.001     Document Type: Article

References (28)

1. Rao R.H. Effects of angiotensin II on insulin sensitivity and fasting glucose metabolism in rats. Am J Hypertens 1994, 7:655-660.
2. Richey J.M., Ader M., Moore D., Bergman R.N. Angiotensin II induces insulin resistance independent of changes in interstitial insulin. Am J Physiol 1999, 277:E920-E926.
3. Henriksen E.J. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2007, 293:R974-R980.
4. Ferrario C.M., Trask A.J., Jessup J.A. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005, 289:H2281-H2290.
5. Santos R.A., Ferreira A.J., Simoes E.S.A.C. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008, 93:519-527.
6. Iusuf D., Henning R.H., van Gilst W.H., Roks A.J. Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives. Eur J Pharmacol 2008, 585:303-312.
7. Velloso L.A., Folli F., Perego L., Saad M.J. The multi-faceted cross-talk between the insulin and angiotensin II signaling systems. Diabetes Metab Res Rev 2006, 22:98-107.
8. Giani J.F., Gironacci M.M., Munoz M.C., Pena C., Turyn D., Dominici F.P. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am J Physiol Heart Circ Physiol 2007, 293:H1154-H1163.
9. Dias-Peixoto M.F., Santos R.A., Gomes E.R., Alves M.N., Almeida P.W., Greco L., et al. Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes. Hypertension 2008, 52:542-548.
10. Santos S.H., Fernandes L.R., Mario E.G., Ferreira A.V., Porto L.C., Alvarez-Leite J.I., et al. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 2008, 57:340-347.
11. Giani J.F., Mayer M.A., Munoz M.C., Silberman E.A., Hocht C., Taira C.A., et al. Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 2009, 296:E262-E271.
12. Vaz-Silva J., Carneiro M.M., Ferreira M.C., Pinheiro S.V., Silva D.A., Silva-Filho A.L., et al. The vasoactive peptide angiotensin-(1-7), its receptor Mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium. Reprod Sci 2009, 16:247-256.
13. Paul M., Poyan Mehr A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006, 86:747-803.
14. Kudoh A., Matsuki A. Effects of angiotensin-converting enzyme inhibitors on glucose uptake. Hypertension 2000, 36:239-244.
15. Jandeleit-Dahm K.A., Tikellis C., Reid C.M., Johnston C.I., Cooper M.E. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 2005, 23:463-473.
16. Munoz M.C., Argentino D.P., Dominici F.P., Turyn D., Toblli J.E. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. J Hypertens 2006, 24:1607-1617.
17. Santos R.A., Ferreira A.J., Pinheiro S.V., Sampaio W.O., Touyz R., Campagnole-Santos M.J. Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs 2005, 14:1019-1031.
18. Iyer S.N., Ferrario C.M., Chappell M.C. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 1998, 31:356-361.
19. Ferrario C.M. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 2006, 47:515-521.
20. Santos R.A., Simoes e Silva A.C., Maric C., Silva D.M., Machado R.P., de Buhr I., et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor. Mas Proc Natl Acad Sci U S A 2003, 100:8258-8263.
21. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006, 7:85-96.
22. Metzger R., Bader M., Ludwig T., Berberich C., Bunnemann B., Ganten D. Expression of the mouse and rat Mas proto-oncogene in the brain and peripheral tissues. FEBS Lett 1995, 357:27-32.
23. Sampaio W.O., Henrique de Castro C., Santos R.A., Schiffrin E.L., Touyz R.M. Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 2007, 50:1093-1098.
24. Lee J., Kim M.S. The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res Clin Pract 2007, 77(Suppl 1):S49-S57.
25. Herath C.B., Warner F.J., Lubel J.S., Dean R.G., Jia Z., Lew R.A., et al. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 2007, 47:387-395.
26. Paizis G., Tikellis C., Cooper M.E., Schembri J.M., Lew R.A., Smith A.I., et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005, 54:1790-1796.
27. Pereira R.M., Dos Santos R.A., Teixeira M.M., Leite V.H., Costa L.P., da Costa Dias F.L., et al. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1-7). J Hepatol 2007, 46:674-681.
28. Lubel J.S., Herath C.B., Tchongue J., Grace J., Jia Z., Spencer K., et al. Angiotensin 1-7, an alternative metabolite of the renin-angiotensin system, is upregulated in human liver disease and has antifibrotic activity in the bile duct ligated rat. Clin Sci (Lond) 2009.